Anti-viral therapy for chronic hepatitis B and cirrhosis: monotherapy or combination?
At present, the response rate of anti-viral therapy for chronic hepatitis B still needs to be increased. Therefore, combination therapy including nucleosides combined with nucleotides, as well as interferon combined with nucleosides and nucleotides, is being explored by many researchers. According t...
Main Author: | |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Department of Journal of Clinical Hepatology
2015-03-01
|
Series: | Linchuang Gandanbing Zazhi |
Subjects: | |
Online Access: | http://www.lcgdbzz.org/qk_content.asp?id=6362&ClassID=212131135 |